Stratos Wealth Partners, Ltd. Sage Therapeutics, Inc. Transaction History

Stratos Wealth Partners, Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 08, 2019	SELL	$81.94 - $139.71 $2,622 - $4,470	-32 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$138.11 - $169.04 $4,419 - $5,409	32 New	32 $5,000
Q2 2018 Aug 13, 2018	SELL	$140.36 - $175.76 $25,545 - $31,988	-182 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$152.15 - $192.33 $22,822 - $28,849	150 Added 468.75%	182 $29,000
Q4 2017 Feb 09, 2018	BUY	$60.72 - $167.34 $1,943 - $5,354	32	32 $5,000

217

48.2M

854K

195K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $414M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.